What is BHRT and how do I know if I need it?

Short answer BHRT = bioidentical hormone replacement therapy. It means using hormones that are chemically identical to the hormones your body makes (estradiol, progesterone, testosterone) to treat symptoms from menopause, perimenopause, low testosterone in men, or other hormone deficiencies. BHRT can be prescribed as FDA‑approved products that are bioidentical (for example micronized progesterone) or as compounded preparations made by pharmacies.

What BHRT does and when it’s used

• Common goals: reduce hot flashes/night sweats, improve sleep and mood, reduce vaginal dryness and painful sex, help low libido, and in some cases reduce bone loss.
• Typical candidates: people with bothersome menopausal or perimenopausal symptoms, people with surgical menopause, men with clinically confirmed low testosterone and symptoms, and people with certain hormone deficiencies after medical treatment.
• It is not a general “wellness” cure; it is a medical treatment with benefits and risks that should be individualized.

How BHRT differs from conventional HRT

• “Bioidentical” refers to molecular structure, not safety. Some conventional HRT products are also bioidentical (for example, FDA‑approved estradiol patches).
• Compounded BHRT (custom mixtures from compounding pharmacies) is popular because of custom dosing or formulations, but it is less regulated than FDA‑approved products and can have inconsistent potency or purity.

Evidence, benefits and risks (brief)

• Benefits: good evidence that estrogen (with or without progesterone) reduces hot flashes and vaginal symptoms and helps sleep and quality of life. Estrogen can also protect bone.
• Risks: combined estrogen/progestin therapy increases risks of blood clots and stroke and — depending on age, duration and type — may be associated with increased breast cancer risk (data come largely from the Women’s Health Initiative and later studies). Timing (starting around menopause vs many years later), dose, route (oral vs transdermal), and type of progestogen can affect risk. Compounded products carry additional uncertainty about dosing and safety.
• There is no strong evidence that compounded “custom” BHRT is safer than FDA‑approved therapies.

How to know if you need it — practical steps

1. Track symptoms: hot flashes/night sweats, irregular periods (perimenopause), sleep problems, mood changes, low libido, vaginal dryness, sexual pain, unexplained fatigue or cognitive changes.
2. See a clinician: primary care, gynecologist, or endocrinologist experienced in menopause/androgen deficiency. A menopause specialist (see resources below) is ideal for complex cases.
3. Medical history and risk assessment: discuss personal/family history of breast cancer, blood clots, stroke, heart disease, liver disease, migraines with aura, and whether you smoke — these affect safety.
4. Basic testing your clinician may order:
   • For women: FSH and estradiol can help confirm menopausal status, though symptoms and age are often sufficient. Consider pelvic exam and mammography per screening guidelines. Bone density (DEXA) if menopausal and at risk for osteoporosis.
   • For men: total testosterone (morning level), SHBG, and related labs repeated to confirm low levels.
   • General baseline labs: TSH, CBC, CMP, lipid panel, and tests for clotting risk if indicated. Note: salivary hormone panels are not reliable for guiding most therapies; serum (blood) testing is preferred.
5. Shared decision: weigh symptom severity vs personal risks and preferences. If therapy is chosen, discuss formulations, dosing, route (patch, gel, cream, oral, pellet), monitoring plan, and duration.

Common prescription options (examples)

• Estradiol patches/gels (bioidentical estradiol): Vivelle‑Dot, Climara — patches provide steady dosing and avoid first‑pass liver metabolism, which may have lower clot risk than some oral estrogens.
• Estradiol gels: EstroGel, Divigel — topical options for systemic estrogen.
• Micronized progesterone: Prometrium — an FDA‑approved, bioidentical progesterone commonly used to protect the uterus when systemic estrogen is used in women with a uterus.
• Testosterone gels (approved for men): AndroGel, Testim, Fortesta — testosterone must be used carefully in women and is off‑label for female sexual dysfunction in many places.
  Note: compounded pellet therapy and creams are available through compounding pharmacies but have pros and cons; discuss variability and regulation with your clinician.

Where to get help and reliable information

• North American Menopause Society (NAMS) — evidence‑based patient information and clinician directory.
• Mayo Clinic Menopause Clinic or the Cleveland Clinic Menopause Center — specialty centers for complex cases and second opinions.
• Lab testing through major labs: LabCorp or Quest Diagnostics for blood hormone testing and DEXA centers for bone density.
  If you prefer telehealth, pick services that use board‑certified clinicians and provide clear lab testing and follow‑up rather than those that only use questionnaires.

When BHRT is NOT recommended or needs caution

• Active or recent (within 5 years) estrogen‑sensitive breast cancer, recent unprovoked blood clots, certain liver disease, uncontrolled hypertension, and some heart disease. These are not automatic exclusions but require specialist input. Pregnancy and breastfeeding are clear contraindications.

Bottom line BHRT can help many people with symptomatic hormone deficiency, but it’s not appropriate for everyone and compounded “natural” claims don’t guarantee safety. The right path is a symptomatic assessment, medical history review, targeted blood testing, and a conversation with a clinician experienced in hormone therapy about risks, benefits, and choice of an FDA‑approved vs compounded product.

If you’d like, tell me:

• your age, sex, main symptoms, and any relevant medical history (clots, cancer, heart disease, smoking), and I can give more tailored next steps and which tests to ask your clinician for.